The kinase-null EphB6 receptor undergoes transphosphorylation in a complex with EphB1

被引:87
作者
Freywald, A
Sharfe, N
Roifman, CM
机构
[1] Hosp Sick Children, Res Inst, Injury & Repair Program, Dept Paediat Infect Immun Div Immunol & Allergy, Toronto, ON M5G 1X8, Canada
[2] Univ Toronto, Toronto, ON M5G 1X8, Canada
关键词
D O I
10.1074/jbc.M108011200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Uniquely for the Eph family of receptor tyrosine kinases, the EphB6 receptor is catalytically inactive due to the alteration of several critical residues in its kinase domain. This has cast doubt upon its ability to participate in cytoplasmic signaling events. We show here that despite its lack of kinase activity, EphB6 undergoes inducible tyrosine phosphorylation upon stimulation with the Eph-B receptor subfamily ligand ephrin-B1. We also demonstrate, for the first time, evidence of cross-talk between Eph receptors. Overexpression of a catalytically active member of the Eph-B subfamily, EphB1, resulted in increased EphB6 phosphorylation. EphB1-induced EphB6 phosphorylation was ligand-dependent and required the functional catalytic activity of EphB1. EphB1 not only transphosphorylated EphB6, but together they also formed a stable hetero-complex. In addition, we identify the proto-oncogene c-Cbl its an EphB6-binding protein. Although EphB6-Cb1 association appeared to be constitutive, Cbl required a functional phosphotyrosine binding domain in order to bind the receptor, whereas its RING finger motif ubiquitin-transfer domain was not necessary. Our findings demonstrate that EphB6 is an actively signaling receptor that undergoes transphosphorylation upon ligand binding and that can initiate specific cytoplasmic signaling events.
引用
收藏
页码:3823 / 3828
页数:6
相关论文
共 64 条
[1]   Roles of ephrinB ligands and EphB receptors in cardiovascular development: demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesis [J].
Adams, RH ;
Wilkinson, GA ;
Weiss, C ;
Diella, F ;
Gale, NW ;
Deutsch, U ;
Risau, W ;
Klein, R .
GENES & DEVELOPMENT, 1999, 13 (03) :295-306
[2]  
BLAKE TJ, 1991, ONCOGENE, V6, P653
[3]   Cell-cell adhesion mediated by binding of membrane-anchored ligand LERK-2 to the EPH-related receptor human embryonal kinase 2 promotes tyrosine kinase activity [J].
Bohme, B ;
Vandenbos, T ;
Cerretti, DP ;
Park, LS ;
Holtrich, U ;
RubsamenWaigmann, H ;
Strebhardt, K .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (40) :24747-24752
[4]   Phosphotyrosine binding domain-dependent upregulation of the platelet-derived growth factor receptor alpha signaling cascade by transforming mutants of Cbl: Implications for Cbl's function and oncogenicity [J].
Bonita, DP ;
Miyake, S ;
Lupher, ML ;
Langdon, WY ;
Band, H .
MOLECULAR AND CELLULAR BIOLOGY, 1997, 17 (08) :4597-4610
[5]   MEMBRANE-BOUND LERK2 LIGAND CAN SIGNAL THROUGH 3 DIFFERENT EPH-RELATED RECEPTOR TYROSINE KINASES [J].
BRAMBILLA, R ;
SCHNAPP, A ;
CASAGRANDA, F ;
LABRADOR, JP ;
BERGEMANN, AD ;
FLANAGAN, JG ;
PASQUALE, EB ;
KLEIN, R .
EMBO JOURNAL, 1995, 14 (13) :3116-3126
[6]   Eph receptor-ligand interactions are necessary for guidance of retinal ganglion cell axons in vitro [J].
Ciossek, T ;
Monschau, B ;
Kremoser, C ;
Löschinger, J ;
Lang, S ;
Müller, BK ;
Bonhoeffer, F ;
Drescher, U .
EUROPEAN JOURNAL OF NEUROSCIENCE, 1998, 10 (05) :1574-1580
[7]   Identification of Elf-1 and B61 as high affinity ligands for the receptor tyrosine kinase MDK1 [J].
Ciossek, T ;
Ullrich, A .
ONCOGENE, 1997, 14 (01) :35-43
[8]  
Daniel TO, 1996, KIDNEY INT, V50, pS73
[9]   LIGANDS FOR EPH-RELATED RECEPTOR TYROSINE KINASES THAT REQUIRE MEMBRANE ATTACHMENT OR CLUSTERING FOR ACTIVITY [J].
DAVIS, S ;
GALE, NW ;
ALDRICH, TH ;
MAISONPIERRE, PC ;
LHOTAK, V ;
PAWSON, T ;
GOLDFARB, M ;
YANCOPOULOS, GD .
SCIENCE, 1994, 266 (5186) :816-819
[10]   The Eph family in the patterning of neural development [J].
Drescher, U .
CURRENT BIOLOGY, 1997, 7 (12) :R799-R807